论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
寻找纯合子家族性高胆固醇血症最佳治疗方法的艰难历程:一病例报告
Authors Xu MJ, Chu JP, Fei WL, Wang J, Zhang YM, Wang Y
Received 25 October 2021
Accepted for publication 13 January 2022
Published 21 March 2022 Volume 2022:15 Pages 97—103
DOI https://doi.org/10.2147/IMCRJ.S345320
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Ronald Prineas
Abstract: Homozygous familial hypercholesterolemia (HoFH) is a rare autosomal recessive genetic disorder. It is difficult to diagnose and treat it at early stage. We present a nine-year-old boy with HoFH from China. At the beginning, he was misdiagnosed as xanthomatosis in the dermatology department of the local hospital, but the disease did not alleviate after three laser ablation operations. Later, blood lipid monitoring, ultrasound of heart and carotid artery were further added in our hospital, and finally the boy was diagnosed with HoFH by genetic testing. A biallelic mutations was observed in the fourth exon of low density lipoprotein receptor (LDLR): c.418G>A (p.E140K). Our patient achieved a relatively satisfactory therapeutic results after a series of lipid-lowering therapies including atorvastatin monotherapy, lipoprotein apheresis and double-filtration plasma pheresis. We found that LDL-C levels obtained 57% reduction from baseline after atorvastatin combined with double-filtration plasma pheresis (DFPP). It was observed that regression of carotid intima-media thickness (cIMT), valve regurgitation and xanthoma occurred after a series of Intensive lipid-lowering therapy.
Keywords: homozygous familial hypercholesterolemia, low density lipoprotein cholesterol, double-filtration plasma pheresis